Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen brokerages that are covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $140.14.
Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. increased their price target on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Mizuho boosted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Monday, March 31st. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Finally, Citigroup upped their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th.
Check Out Our Latest Analysis on CAH
Cardinal Health Price Performance
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, analysts expect that Cardinal Health will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.55%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.
Hedge Funds Weigh In On Cardinal Health
Large investors have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. lifted its stake in Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock valued at $3,871,000 after acquiring an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp boosted its holdings in shares of Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after buying an additional 3,576 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after buying an additional 42,082 shares during the last quarter. Consolidated Planning Corp grew its position in Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock valued at $1,056,000 after buying an additional 2,552 shares during the period. Finally, Flputnam Investment Management Co. increased its holdings in Cardinal Health by 1.8% during the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company’s stock worth $21,358,000 after buying an additional 3,148 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
- Five stocks we like better than Cardinal Health
- Short Selling – The Pros and Cons
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- 3 Healthcare Dividend Stocks to Buy
- Are Tariffs Threatening Disney’s Comeback Story?
- Should You Invest in Penny Stocks?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.